Introduction

Imexpharm Corporation is a Vietnam-based pharmaceutical manufacturing and distributing company. The Company primarily manufactures, markets and trades pharmaceutical products, materials and equipment, including drugs, traditional medicine, cosmetics and drinks. It is also involved in the provision of packaging and warehousing services specialized for pharmaceutical storage. The Company manufactures more than 190 drugs, in which more than 30 of them are franchised to foreign pharmaceutical manufacturers. As of December 31, 2007, products manufactured by the Company contributed to 66.72% of total revenue. It has six branches, one pharmaceutical center, two factories and two alliances. Its distribution main market is in the South. With annual revenue of approximately VND 350 billion, the company accounts for nearly 5% of the total domestic shares and rank in the top 5 Vietnamese pharmaceutical companies with highest revenue.

Business sector

  • Manufacturing, trading, importing, exporting pharmaceuticals, medical equipment and tools, materials for production of medicine packing;
  • Manufacturing and trading traditional medicines, cosmetics, foods, functional foods, drinks, alcoholic drinks, soda and sterilizing substances;
  • Providing services for preserving drugs and medicinal materials;
  • Growing, processing and trading medicinal materials;
  • Providing entertainment services;
  • Investing in finance, property.

History

Date of incorporation 28/09/1983
Certificate of registration number 1400384433
Date of issue 07/11/2023
Capital 700,384,490,000
Tax Code 1400384433
Sectors & Industries Health Care > Pharmaceuticals

  • The precursor of Imexpharm Corporation was the Dong Phap Pharmaceutical Joint Enterprise under Dong Thap Department of Health.
  • In Nov 1992, the enterprise was renamed to Dong Phap Pharmaceutical Company under the People’s Committee of Dong Thap Province.
  • In Nov 1999, Dong Thap Pharmaceutical Company was renamed to the Central Pharmaceutical Company No 7 under Vietnam Pharmaceutical Corporation (VINAPHARM).
  • In Jul 2001, the company was transformed into Imexpharm Pharmaceutical Joint Stock Company with charter capital of VND 22 billion.
  • In Mar 2005, charter capital was adjusted to VND 44 billion.
  • From Apr 12, 2006, the company’s shares were officially listed on the Ho Chi Minh City Stock Exchange (Stock code: IMP)
  • By Dec 31, 2010, the company's charter capital was VND 116.598.200.000. It plans to  adjust its charter capital to VND 160.000.000.000 in 2010.
  • The company was approved to increase its charter capital to VND167,058,100,000, based on the adjusted business certificate dated November 06 by the People’s Committee of Dong Thap province.

Listing information

Date of listing 07/11/2023
Stock exchange HOSTC
Par Value 10,000
Initial Listing Price 100,000
Listing Volume 70,038,449
Total Listing Value 700,384,490,000

Management team

Chun Chaerhan Chairman of the Board of Directors
Trương Minh Hùng Members of the Board
Chung Suyong Members of the Board
Hoàng Đức Hùng Members of the Board
Trần Thị Đào Members of the Board
Hàn Thị Khánh Vinh Members of the Board
Trần Thị Đào Chief of Executive Officer
Ngô Minh Tuấn Deputy CEO
Nguyễn An Duy Deputy CEO
Nguyễn Thomas Thanh Deputy CEO
Lê Văn Nhã Phương Deputy CEO
Huỳnh Văn Nhung Deputy CEO
Nguyễn An Duy Director of Finance
Dương Hoàng Vũ Chief Accountant
Nguyễn An Duy Representative Spokesman